BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34484309)

  • 1. Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer.
    Wu W; Jia G; Chen L; Liu H; Xia S
    Front Genet; 2021; 12():731625. PubMed ID: 34484309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression levels and prognostic values of annexins in liver cancer.
    Zhuang C; Wang P; Sun T; Zheng L; Ming L
    Oncol Lett; 2019 Dec; 18(6):6657-6669. PubMed ID: 31807177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of annexin A family in glioblastoma.
    Xu H; Wu X; Dou Y; Zheng W
    Ir J Med Sci; 2022 Aug; 191(4):1539-1547. PubMed ID: 34398393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
    Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
    Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexins induce curvature on free-edge membranes displaying distinct morphologies.
    Boye TL; Jeppesen JC; Maeda K; Pezeshkian W; Solovyeva V; Nylandsted J; Simonsen AC
    Sci Rep; 2018 Jul; 8(1):10309. PubMed ID: 29985397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family.
    Wang LH; Cao B; Li YL; Qiao BP
    BMC Cancer; 2023 Jul; 23(1):674. PubMed ID: 37464398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of an Annexin-Related Prognostic Signature and Therapeutic Targets for Bladder Cancer: Integrative Analysis.
    Yao X; Qi X; Wang Y; Zhang B; He T; Yan T; Zhang L; Wang Y; Zheng H; Zhang G; Guo X
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
    Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
    Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
    Silva TA; Azevedo H
    J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis the diagnosis, malignant progression and immune infiltrate of ANXA6 in prostate cancer.
    Huang B; Yang K
    Genes Genomics; 2023 Sep; 45(9):1197-1209. PubMed ID: 37311953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer.
    Shim UJ; Lee IS; Kang HW; Kim J; Kim WT; Kim IY; Ryu KH; Choi YH; Moon SK; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Korean J Urol; 2013 Sep; 54(9):631-7. PubMed ID: 24044099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer.
    Ouyang S; Liu JH; Ni Z; Ding GF; Wang QZ
    Oncol Lett; 2020 Jul; 20(1):828-840. PubMed ID: 32566010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
    Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an immunotherapy-responsive molecular subtype of bladder cancer.
    Song BN; Kim SK; Mun JY; Choi YD; Leem SH; Chu IS
    EBioMedicine; 2019 Dec; 50():238-245. PubMed ID: 31735557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
    Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
    BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
    Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
    Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of membrane crosslinking and curvature induction by annexins.
    Mularski A; Sønder SL; Heitmann ASB; Pandey MP; Khandelia H; Nylandsted J; Simonsen AC
    Sci Rep; 2022 Dec; 12(1):22568. PubMed ID: 36581673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.